Boston Scientific Corporation last reported quarterly results on Oct 28, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026): revenue of $5.1 billion (+1.4% year over year) and diluted EPS of $0.40. It usually reports 22–35 days after a quarter ends. Based on that pattern, the next release is estimated for around Feb 3, 2027.
Results for Q4 FY2026, the quarter ending around Dec 31, 2026. Expected on a Wednesday. Based on last year's release for the same quarter on Feb 4, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 22–35 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Oct 28, 2026
28 days after quarter end
|
Q3 FY2026
ended Sep 30, 2026
|
5,138
+1.4%
|
580
-23.2%
|
0.40
-21.6%
|
|
Jul 29, 2026
29 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
5,442
+7.5%
|
905
+13.8%
|
0.61
+15.1%
|
|
Apr 22, 2026
22 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
5,203
+11.6%
|
1,339
+99.3%
|
0.90
+100.0%
|
|
Feb 4, 2026
35 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
5,286
+15.9%
|
670
+19.2%
|
0.45
+18.5%
|
|
Oct 22, 2025
22 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
5,065
+20.3%
|
755
+61.3%
|
0.51
+59.4%
|
|
Jul 23, 2025
23 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
5,061
+22.8%
|
795
+146.9%
|
0.53
+140.9%
|
|
Apr 23, 2025
23 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
4,663
+20.9%
|
672
+36.3%
|
0.45
+36.4%
|
|
Feb 5, 2025
36 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
4,561
+22.4%
|
562
+11.5%
|
0.38
+10.9%
|
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- BSX (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Marlborough, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 885725
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
- West Pharmaceutical Services Inc WST
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.